89 related articles for article (PubMed ID: 18646053)
1. CCL2 induces prostate cancer transendothelial cell migration via activation of the small GTPase Rac.
van Golen KL; Ying C; Sequeira L; Dubyk CW; Reisenberger T; Chinnaiyan AM; Pienta KJ; Loberg RD
J Cell Biochem; 2008 Aug; 104(5):1587-97. PubMed ID: 18646053
[TBL] [Abstract][Full Text] [Related]
2. PAR1-mediated RhoA activation facilitates CCL2-induced chemotaxis in PC-3 cells.
Loberg RD; Tantivejkul K; Craig M; Neeley CK; Pienta KJ
J Cell Biochem; 2007 Aug; 101(5):1292-300. PubMed ID: 17492768
[TBL] [Abstract][Full Text] [Related]
3. Bi-directional interactions of prostate cancer cells and bone marrow endothelial cells in three-dimensional culture.
Barrett JM; Mangold KA; Jilling T; Kaul KL
Prostate; 2005 Jun; 64(1):75-82. PubMed ID: 15651029
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Rho/ROCK signalling in small cell lung cancer migration through human brain microvascular endothelial cells.
Li B; Zhao WD; Tan ZM; Fang WG; Zhu L; Chen YH
FEBS Lett; 2006 Jul; 580(17):4252-60. PubMed ID: 16828752
[TBL] [Abstract][Full Text] [Related]
5. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity.
Zhang Y; Han G; Fan B; Zhou Y; Zhou X; Wei L; Zhang J
Eur J Pharmacol; 2009 Mar; 606(1-3):172-9. PubMed ID: 19171136
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells.
Ummanni R; Teller S; Junker H; Zimmermann U; Venz S; Scharf C; Giebel J; Walther R
FEBS J; 2008 Nov; 275(22):5703-13. PubMed ID: 18959755
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
8. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
[TBL] [Abstract][Full Text] [Related]
9. Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation.
Kirschenbaum A; Liu XH; Yao S; Leiter A; Levine AC
Ann N Y Acad Sci; 2011 Nov; 1237():64-70. PubMed ID: 22082367
[TBL] [Abstract][Full Text] [Related]
10. The role of tumor microenvironment in prostate cancer bone metastasis.
Morrissey C; Vessella RL
J Cell Biochem; 2007 Jul; 101(4):873-86. PubMed ID: 17387734
[TBL] [Abstract][Full Text] [Related]
11. PTHrP-induced MCP-1 production by human bone marrow endothelial cells and osteoblasts promotes osteoclast differentiation and prostate cancer cell proliferation and invasion in vitro.
Lu Y; Xiao G; Galson DL; Nishio Y; Mizokami A; Keller ET; Yao Z; Zhang J
Int J Cancer; 2007 Aug; 121(4):724-33. PubMed ID: 17390372
[TBL] [Abstract][Full Text] [Related]
12. The prostate transglutaminase (TGase-4, TGaseP) regulates the interaction of prostate cancer and vascular endothelial cells, a potential role for the ROCK pathway.
Jiang WG; Ablin RJ; Kynaston HG; Mason MD
Microvasc Res; 2009 Mar; 77(2):150-7. PubMed ID: 18983858
[TBL] [Abstract][Full Text] [Related]
13. CCL2 is a potent regulator of prostate cancer cell migration and proliferation.
Loberg RD; Day LL; Harwood J; Ying C; St John LN; Giles R; Neeley CK; Pienta KJ
Neoplasia; 2006 Jul; 8(7):578-86. PubMed ID: 16867220
[TBL] [Abstract][Full Text] [Related]
14. Preventing the activation or cycling of the Rap1 GTPase alters adhesion and cytoskeletal dynamics and blocks metastatic melanoma cell extravasation into the lungs.
Freeman SA; McLeod SJ; Dukowski J; Austin P; Lee CC; Millen-Martin B; Kubes P; McCafferty DM; Gold MR; Roskelley CD
Cancer Res; 2010 Jun; 70(11):4590-601. PubMed ID: 20484042
[TBL] [Abstract][Full Text] [Related]
15. Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.
Zhang J; Lu Y; Pienta KJ
J Natl Cancer Inst; 2010 Apr; 102(8):522-8. PubMed ID: 20233997
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y
Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805
[TBL] [Abstract][Full Text] [Related]
17. Possible mechanism of CCL2-induced Akt activation in prostate cancer cells.
Mizutani K; Roca H; Varsos Z; Pienta KJ
Anticancer Res; 2009 Aug; 29(8):3109-13. PubMed ID: 19661323
[TBL] [Abstract][Full Text] [Related]
18. G(alpha)12-mediated pathway promotes invasiveness of nasopharyngeal carcinoma by modulating actin cytoskeleton reorganization.
Liu SC; Jen YM; Jiang SS; Chang JL; Hsiung CA; Wang CH; Juang JL
Cancer Res; 2009 Aug; 69(15):6122-30. PubMed ID: 19602597
[TBL] [Abstract][Full Text] [Related]
19. Identification of mu-crystallin as an androgen-regulated gene in human prostate cancer.
Malinowska K; Cavarretta IT; Susani M; Wrulich OA; Uberall F; Kenner L; Culig Z
Prostate; 2009 Jul; 69(10):1109-18. PubMed ID: 19353593
[TBL] [Abstract][Full Text] [Related]
20. The Cdk inhibitor p57(Kip2) controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics.
Vlachos P; Joseph B
Oncogene; 2009 Nov; 28(47):4175-88. PubMed ID: 19734939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
